BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 34217946)

  • 1. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
    Ji W; Wang T; Xu Y; An R; Liang K; Wang X
    Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banxia Xiexin decoction ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis via inhibiting serine-threonine protein kinase (Akt)/mitogen-activated protein kinase (MAPK) signaling pathway.
    Ji W; Liu W; Huo Y; Hu C; Zhang Y
    Biotechnol Appl Biochem; 2023 Aug; 70(4):1530-1542. PubMed ID: 36806191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematical strategy for quality markers screening of different methods processing Platycodonis radix based on phytochemical analysis and the impact on Chronic Obstructive Pulmonary Disease.
    Bai T; Guo J; Deng Y; Zheng Y; Shang J; Zheng P; Liu M; Yang M; Zhang J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117311. PubMed ID: 37827295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.
    Liu Z; Zheng Z; Wang T; Liu Z; Zuo Z
    J Pharm Pharmacol; 2024 May; 76(5):462-478. PubMed ID: 37832514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach.
    Li C; Yang W; Meng Y; Feng L; Sun L; Li Z; Liu X; Li M
    Metab Brain Dis; 2023 Oct; 38(7):2315-2325. PubMed ID: 37556042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and mechanism of Banxia Xiexin decoction in colorectal cancer: A network pharmacology approach.
    Wang Y; Zhao T; Huang C; Liu F; Zhang Y; Kong D; Fan Z
    Phytomedicine; 2024 Jan; 123():155174. PubMed ID: 38039904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential molecular mechanism of Banxia Xiexin Decoction in treatment of colon cancer based on network pharmacology and molecular docking technology].
    Luo YT; Lin LF; Liu YL; Shi GL; Wu YQ; Yang AH; Li H
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5753-5761. PubMed ID: 33496116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the chemical profile and pharmacological mechanism of Jinlingzi powder against bile reflux gastritis using ultra-high performance liquid chromatography coupled with Q exactive focus mass spectrometry, network pharmacology, and molecular docking.
    Hui R; Lintao Z; Kai G; Yuanyuan Y; Xiaomin C; Jing HU; Zhiyong C; Ye LI
    J Tradit Chin Med; 2023 Oct; 43(6):1209-1218. PubMed ID: 37946483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the active compounds and mechanism of action of TongFu XieXia Decoction for treating intestinal obstruction using network pharmacology combined with ultra-high performance liquid chromatography-quadrupole-orbitrap mass spectrometry.
    Ma L; Wu Y; Luo J; Li F; Zhang M; Cai Y; Dai Y; Pi Z; Zheng F; Yue H
    Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9664. PubMed ID: 38124169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis.
    Wang W; Xu C; Li X; Wang Z; Yang J; Shen Y; Shi M; Chen L; Zhang L; Guo Y; Wang B; Zhang T; Pu Y
    J Ethnopharmacol; 2021 Sep; 277():114197. PubMed ID: 34004261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy.
    Li B; Rui J; Ding X; Yang X
    J Ethnopharmacol; 2019 Apr; 233():158-168. PubMed ID: 30590198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.
    Yu Y; Zhang G; Han T; Huang H
    BMC Complement Med Ther; 2020 Jun; 20(1):199. PubMed ID: 32600331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations.
    Chang C; Feng W; Sun M; Yu X; Sun Z
    Comput Math Methods Med; 2022; 2022():4237040. PubMed ID: 36158124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of LC-LTQ-Orbitrap-MS and Network Pharmacology to Analyze the Active Components of Sijunzi Decoction and their Mechanism of Action Against Cytotoxicity-associated Premature Ovarian Insufficiency.
    Chen Y; Han S; Kang A; Fu R; Chen L; Guo J; Wang Q
    Comb Chem High Throughput Screen; 2023; 26(14):2437-2451. PubMed ID: 36872360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Huangqi Guizhi Wuwu Decoction in treatment of rheumatoid arthritis based on UPLC-LTQ-Orbitrap-MS, network pharmacology, and cell experiment].
    Lu WW; Qiu YJ; Fan XF; Yu GY; Wu GL
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6454-6464. PubMed ID: 34994138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing active ingredients, potential targets, and action mechanism of Ermiao fang for treating endometritis based on network pharmacology strategy.
    Zhang C; Su T; Yu D; Wang F; Yue C; Wang HQ
    J Ethnopharmacol; 2020 Oct; 260():113051. PubMed ID: 32505843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo exploration of the anti-atopic dermatitis mechanism of action of Tibetan medicine Qi-Sai-Er-Sang-Dang-Song decoction.
    Liu J; Tao Y; Zou X; Liu Q; Meng X; Zhang Y; Su J
    J Ethnopharmacol; 2023 Apr; 306():116155. PubMed ID: 36634726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
    Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
    J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the active components, prospective targets, and molecular mechanism of Baihe Zhimu decoction for treating depression using network pharmacology-based analysis.
    Wang HQ; Liu HT; Wang L; Min L; Chen B; Li H
    J Ethnopharmacol; 2021 Dec; 281():114586. PubMed ID: 34464700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.